MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. - Wikidata - awgldk - TriplyDB

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

http://www.wikidata.org/entity/Q35730683

about

Noncoding RNA in oncogenesis: a new era of identifying key players Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc.MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44 Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulation miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.The regulation and function of microRNAs in kidney diseases.MicroRNA-based screens for synthetic lethal interactions with c-Myc Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).The Potential of MicroRNAs as Prostate Cancer Biomarkers.Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells.MicroRNA expression profiling of Xp11 renal cell carcinoma.A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs.MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.

P2860

Q26823718-B3A968AB-2DA2-44CE-9E44-D1607D9BC420 Q33694120-72752AF7-8609-4798-8C94-3DB6FD63212B Q34558930-BA4591EA-67AE-4387-A726-5B05E786AFA4 Q35030251-9973C26F-E363-4911-86F8-F70B9B5306A4 Q35096116-5F2CD7A8-5677-4297-A959-B0FB0EBF1523 Q35664592-22A7A06B-C7E5-4430-8460-C723D9C952AF Q35669189-44FE6316-0A36-4692-8B5A-931CE49241EA Q35781321-3A321451-1417-4B27-BFCF-E49DD55F95E8 Q35913035-87FCE167-6C06-4361-9299-9C8D2B3785BB Q36152135-42A463AD-24AF-42C0-91F9-9D868629206A Q36191693-C28448C6-3111-49A6-8628-C73C7EB63AFB Q36199659-E947F3C0-927C-4D74-9AED-A1437394771A Q36339995-5A46E8BF-440A-419A-8BC3-3B72D6200F2A Q36952171-24E8B68C-23EB-4CA8-9960-CAF7A3FB576A Q36960910-2B3F3E26-1B62-453F-B545-D94352B17936 Q37495218-C3DD55DC-8551-4017-BFD5-6A95EB2577A8 Q37579970-7FA85E69-1711-4CEB-A6BC-1311246E3181 Q38113142-4D0528F4-EB10-4558-8876-0013F30A0235 Q38356005-047B5FEB-AB64-4B7C-8562-61EF7A77ED74 Q38710305-E3CE0C52-73FB-499B-82A4-28B7A295B1C0 Q38755966-FD3AC4F1-4C09-40AE-98A0-9DBF0FF6CC42 Q38968740-8E9BBF95-2692-4FBB-A84C-FDAB9C63345D Q50201255-B6C4C25A-E352-4913-8C8E-ABEB361188EE Q50726690-EEFCA2AB-68AC-4039-AE2A-8DDBB12C54FC Q54185573-03AD013A-236F-4053-867B-FCBC9B76D081 Q55245371-16442F6C-107E-452B-AA94-7FF5733862B4

P2860

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

http://www.wikidata.org/entity/Q35730683

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@ast

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@en

type

label

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@ast

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@en

prefLabel

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@ast

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@en

P1433

Q35730683-472E7268-6053-43A4-AF0F-1DA6359DEEB3

P1476

Q35730683-FD05919B-173B-40DE-9CF8-B0F10EBCD844

P2093

Q35730683-00C0996B-B24C-48EE-9629-BEC979867BBB

Q35730683-334843D8-566A-4319-81B6-13E31B4D3D24

Q35730683-453CF6B2-EB48-4C4F-BA8A-A487BD12536A

Q35730683-62507F01-7BF6-4407-9416-81D45706505F

Q35730683-851E0D29-1986-400C-BFBB-65F286C87A46

Q35730683-97D328AD-7651-424D-B920-5BCE2675013D

Q35730683-9BEB840D-459A-443D-827B-61273A6028F5

Q35730683-C01A3587-DC53-443B-932B-E0C800D3052B

Q35730683-CF429E5A-1F7D-4F7F-85A4-96D1DF4B6908

P2860

Q35730683-0454B4F8-D2C9-4E43-9F3D-FAB8D088EDD0

Q35730683-0574AE9C-28FB-46F7-B721-DD51758A1B7D

Q35730683-1679F670-4F40-46E4-A118-3C71CC437219

Q35730683-16852FB7-C189-4E8C-9C58-70E0B890E239

Q35730683-1E473EE6-0C3C-4CD5-928B-0BCE2D0B93E9

Q35730683-21FD43D9-DF67-4EF4-A9AC-85BF036DE1DD

Q35730683-22BDE671-2ABE-48C3-8940-58A1E561373D

Q35730683-365CA9B2-4F66-462A-BD97-1ED346B270A6

Q35730683-37AC6D0C-2ABA-40C4-9196-600CFADF274D

Q35730683-3A53CBBE-8194-4918-8E60-83EB3F724895

P304

Q35730683-38C2418E-6397-4173-AB37-E90387E31155

P31

Q35730683-B9FB1763-5CDC-4276-90B5-8339423849DB

P356

Q35730683-57955D4E-027D-4C1B-8280-CCAA71735917

P407

Q35730683-7B510643-E0DD-4F05-B131-5E49829D363D

P433

Q35730683-7E5E8F2C-2218-4F5E-8507-F450C667E806

P478

Q35730683-ACD91052-F098-4FD0-8637-3410EEFA51A2

P577

Q35730683-BC7F24EA-B888-46A3-A6B7-18A1CD4E90A8

P5875

Q35730683-C7E0BA3D-E4DE-4F07-B4DB-4406C9C01426

P698

Q35730683-B031305A-FB9A-45D9-8956-4914D5BF3F66

P921

Q35730683-2234A162-08B3-4C55-8215-58215CFD07F7

P932

Q35730683-7EAB7F45-1EB7-4498-9BB3-85148DBED86B

P356

P1433

P1476

MicroRNA-34a suppresses malign ...... in human renal cell carcinoma.

@en

P2093

Ashish Gupta

http://www.w3.org/2001/XMLSchema#string

Hiroshi Hirata

http://www.w3.org/2001/XMLSchema#string

Inik Chang

http://www.w3.org/2001/XMLSchema#string

Koji Ueno

http://www.w3.org/2001/XMLSchema#string

Rajvir Dahiya

http://www.w3.org/2001/XMLSchema#string

Shahana Majid

http://www.w3.org/2001/XMLSchema#string

Sharanjot Saini

http://www.w3.org/2001/XMLSchema#string

Soichiro Yamamura

http://www.w3.org/2001/XMLSchema#string

Yuichiro Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

c-Myc regulates transcriptional pause release

miR-19 is a key oncogenic component of mir-17-92

miR-34a repression of SIRT1 regulates apoptosis

Rho GTPases: biochemistry and biology

A microRNA polycistron as a potential human oncogene

Rho GTPases in cell biology

c-Myc-regulated microRNAs modulate E2F1 expression

c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis

Controlling the elongation phase of transcription with P-TEFb

P304

294-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGR286

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51869141

http://www.w3.org/2001/XMLSchema#string

P698

22159222

http://www.w3.org/2001/XMLSchema#string

P921

P932

3271269

http://www.w3.org/2001/XMLSchema#string